China proposes to treat Alzheimer’s with new drug

China proposes to treat Alzheimer’s with a new drug

Syllabus subtopic: Issues relating to development and management of Social Sectors/Services relating to Health, Education, Human Resources

News: China recently announced that a new drug, meant to potentially treat Alzheimer’s disease, will be available to Chinese patients by the end of this year. Called GV-971 or “Oligomannate”, it is a seaweed-based drug, administered orally.

Prelims and Mains focus All about Alzheimer’s, treatment and concerns.

About Alzheimer’s disease

It is a progressive brain disorder that typically affects people older than 65. When it affects younger individuals, it is considered early onset.
The disease destroys brain cells and nerves, and disrupts the message-carrying neurotransmitters.
Eventually, a person with Alzheimer’s loses the ability to perform day-to-day activities.

Symptoms include memory loss, difficulty in completing familiar tasks, confusion with time or place, problems in speaking and writing, decreased or poor judgment, and changes in mood and personality. Alzheimer’s disease is also the most common cause of dementia — which is a syndrome and not a disease in itself, and whose symptoms include loss of memory, thinking skills, problems with language, changes in mood and deterioration in behaviour.

Treatment:

There is no cure for Alzheimer’s because its exact causes are not known. Most drugs being developed try to slow down or stop the progression of the disease.

There is a degree of consensus in the scientific community that Alzheimer’s involves two proteins, called beta amyloids and tau. When levels of either protein reach abnormal levels in the brain, it leads to the formation of plaque, which gets deposited between neurons, damaging and disrupting nerve cells.
Most existing drugs for Alzheimer’s try to target these proteins to manage some of the symptoms of Alzheimer’s

Source: Indian Express

Join Our Telegram

Inclusive growth and issues arising from it.

Iran Nuclear Deal (JCPOA)

Pradhan Mantri Suryodaya Yojana

06 Feb, 24
SHARE

Recently, Prime Minister announced Pradhan Mantri Suryodaya Yojana under which 1 crore households will get rooftop solar power systems. India’s Status of Current Solar Capacity India currently stands at 4th place globally in solar power capacity. As per Ministry of New an

Foreign Contribution Regulation Act (FCRA)- NGO

06 Feb, 24
SHARE

The Foreign Contribution Regulation Act, 2010 (FCRA) registration of two prominent non-governmental organisations (NGOs) — Centre for Policy Research (CPR) and World Vision India (WVI) have been cancelled this month. What is FCRA? Key provisions of FCRA, 2010 Key aspects Description

Voice clone-AI

06 Feb, 24
SHARE

Voice clone fraud has been on the rise in India. AI voice cloning – It is the process of creating a synthetic replica of a person’s voice through machine learning and speech synthesis technology.It is called as voice deepfakesor audio deepfakes. Objective – To achieve a high level of na

Science communication- how to promote

06 Feb, 24
SHARE

Steps taken by India to promote Science Communication Publications and Information Directorate (PID) - An organisation under Council of Science and Industrial Research (CSIR) established in 1951 for publishing and disseminating scientific information in India. National science magazines- The PI

Universal Basic Income (UBI)- Analysis

05 Feb, 24
SHARE

Universal Basic Income (UBI) can strengthen welfare architecture and unlock the nation’s latent demographic potential. UBI - It is an income support mechanism typically intended to reach all or a very large portion of the population regardless of their earnings or employment status. Objective- To provide enough to co